Skip Navigation

European Heart Journal 2002 23(11):892-900; doi:10.1053/euhj.2001.2971
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brignole, M.
Right arrow Articles by Verlato, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brignole, M.
Right arrow Articles by Verlato, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation

M. Brignolea,f1, C. Menozzib, M. Gasparinic, M. G. Bongiornid, G.L. Bottoe, R. Omettof, P. Albonig, C. Brunah, A. Vincentii and R. Verlatoj

a Department of Cardiology and Arrhythmologic Center, Ospedali Riuniti, Lavagna, Italy
b Department of Interventional Cardiology and Arrhythmologic Center, Ospedale S Maria Nuova, Reggio Emilia, Italy
c Department of Cardiology, Istituto Humanitas, Milano, Italy
d Department of Cardiology, Ospedale Cisanello, Pisa, Italy
e Department of Cardiology, Ospedale S. Anna, Como, Italy
f Department of Cardiology, Ospedale S. Bortolo, Vicenza, Italy
g Department of Cardiology, Ospedale Civile, Cento, Italy
h Department of Cardiology, Ospedale S Croce, Cuneo, Italy
i Department of Cardiology, Ospedale S Gerardo, Monza, Italy
j Department of Cardiology, Ospedale Civile P. Cosma, Camposampiero, Italy

revised August 7, 2001; accepted August 15, 2001

Abstract

Aims Permanent atrial fibrillation develops in many patients after ablation and pacing therapy. We compared a strategy that initially allowed patients to remain in atrial fibrillation with a strategy that initially attempted to restore and maintain sinus rhythm.

Methods and Results In this multicentre randomized controlled trial, 68 patients affected by severely symptomatic paroxysmal atrial fibrillation were assigned, after successful atrioventricular junction ablation and pacing treatment, to antiarrhythmic drug therapy with amiodarone, propafenone, flecainide or sotalol and were compared with 69 patients assigned, after successful AV junction ablation and pacing treatment, to no antiarrhythmic drug therapy. The patients were followed-up for 12 to 24 months (mean 16±4). The drug arm patients had a 57% reduction in the risk of developing permanent atrial fibrillation (21% vs 37%,P =0·02). Evaluation after 12 months revealed similar quality of life scores and echocardiographic parameters in the two groups, but the drug arm patients had more episodes of heart failure and hospitalizations (P=0·05). The outcome was similar between the 40 patients who developed permanent atrial fibrillation and the 97 who did not.

Conclusion Conventional antiarrhythmic therapy reduces the risk of development of permanent atrial fibrillation after ablation and pacing therapy. The present data do not support the concept that the development of permanent atrial fibrillation is related to an adverse outcome when a perfect control of heart rate is obtained by ablation and pacing. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved

Key Words: Catheter ablation, atrial fibrillation, pacemakers, antiarrhythmia agents, atrioventricular node

f1 Correspondence: Michele Brignole, Department of Cardiology and Arrhythmologic Centre, Ospedali Riuniti, Via don Bobbio, 16032 Lavagna, Italy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
D. Roy, M. Talajic, S. Nattel, D. G. Wyse, P. Dorian, K. L. Lee, M. G. Bourassa, J. M. O. Arnold, A. E. Buxton, A. J. Camm, et al.
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
N. Engl. J. Med., June 19, 2008; 358(25): 2667 - 2677.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
T. R. Betts
Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients
Europace, April 1, 2008; 10(4): 425 - 432.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al.
Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA)
Eur. Heart J., November 2, 2007; 28(22): 2803 - 2817.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al.
Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association
Europace, November 1, 2007; 9(11): 1006 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Brignole
A novel use of cardiac pacing to improve cardiac function, quality of life and (hopefully) survival in patients with heart failure and permanent atrial fibrillation
Eur. Heart J., November 2, 2002; 23(22): 1732 - 1736.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Raj and D.G. Wyse
Rhythm control for paroxysmal atrial fibrillation after AV junction ablation: is it worth the effort?
Eur. Heart J., June 1, 2002; 23(11): 845 - 848.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.